167 related articles for article (PubMed ID: 29374392)
1. p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors.
Faccion RS; Bernardo PS; de Lopes GPF; Bastos LS; Teixeira CL; de Oliveira JA; Fernandes PV; Dubois LG; Chimelli L; Maia RC
Cell Oncol (Dordr); 2018 Apr; 41(2):141-157. PubMed ID: 29374392
[TBL] [Abstract][Full Text] [Related]
2. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.
Saito T; Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Hidaka T; Arita K; Kurisu K
J Neurooncol; 2007 Apr; 82(2):193-8. PubMed ID: 17151933
[TBL] [Abstract][Full Text] [Related]
3. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
4. Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades.
Lebelt A; Rutkowski R; Och W; Jaczun K; Dziemiańczyk-Pakieła D; Milewski R; Mariak Z; Reszeć J
Adv Med Sci; 2016 Sep; 61(2):237-243. PubMed ID: 26995334
[TBL] [Abstract][Full Text] [Related]
5. p53 protein overexpression in astrocytic neoplasms.
Cho MY; Jung SH; Kim TS
Yonsei Med J; 1995 Dec; 36(6):521-6. PubMed ID: 8599254
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.
Ellison DW; Steart PV; Bateman AC; Pickering RM; Palmer JD; Weller RO
J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):413-9. PubMed ID: 7561922
[TBL] [Abstract][Full Text] [Related]
7. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical pattern of P53 protein in human astrocytic tumors.
Howng SL; Hwang SL; Chai CY; Lin HJ
Kaohsiung J Med Sci; 1996 May; 12(5):279-84. PubMed ID: 8676433
[TBL] [Abstract][Full Text] [Related]
9. Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma.
Baytekin F; Tuna B; Mungan U; Aslan G; Yorukoglu K
Urol Oncol; 2011; 29(5):502-7. PubMed ID: 19945306
[TBL] [Abstract][Full Text] [Related]
10. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas.
Varughese RK; Skjulsvik AJ; Torp SH
Pathol Res Pract; 2017 Apr; 213(4):339-347. PubMed ID: 28214203
[TBL] [Abstract][Full Text] [Related]
12. Survivin and laryngeal carcinoma prognosis: nuclear localization and expression of splice variants.
Marioni G; Agostini M; Bedin C; Blandamura S; Stellini E; Favero G; Lionello M; Giacomelli L; Burti S; D'Angelo E; Nitti D; Staffieri A; De Filippis C
Histopathology; 2012 Aug; 61(2):247-56. PubMed ID: 22416874
[TBL] [Abstract][Full Text] [Related]
13. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
14. p53 abnormality and tumor invasion in patients with malignant astrocytoma.
Momota H; Narita Y; Matsushita Y; Miyakita Y; Shibui S
Brain Tumor Pathol; 2010 Oct; 27(2):95-101. PubMed ID: 21046311
[TBL] [Abstract][Full Text] [Related]
15. KLF4 expression and apoptosis-related markers in gastric cancer.
Krstic M; Stojnev S; Jovanovic L; Marjanovic G
J BUON; 2013; 18(3):695-702. PubMed ID: 24065485
[TBL] [Abstract][Full Text] [Related]
16. Expression of apoptosis and its related protein in astrocytic tumors.
Takekawa Y; Sawada T; Sakurai I
Brain Tumor Pathol; 1999; 16(1):11-6. PubMed ID: 10532418
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and proliferation: correlation with p53 in astrocytic tumours.
Sarkar C; Karak AK; Nath N; Sharma MC; Mahapatra AK; Chattopadhyay P; Sinha S
J Neurooncol; 2005 Jun; 73(2):93-100. PubMed ID: 15981097
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
Rajmohan KS; Sugur HS; Shwetha SD; Ramesh A; Thennarasu K; Pandey P; Arivazhagan A; Santosh V
J Clin Pathol; 2016 Aug; 69(8):686-94. PubMed ID: 26743027
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle aberration in ameloblastoma and adenomatoid odontogenic tumor: As evidenced by the expression of p53 and survivin.
Shaikh Z; Niranjan KC
Indian J Dent Res; 2015; 26(6):565-70. PubMed ID: 26888232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
